Latest News & Features
Big Pharma
For many of the key questions relating to the grant of SPCs, there is some variance in the practice of national patent offices, even where there is guidance from the CJEU, as Simon Spink and Adrian Chew of Bristows explain. 14 July 2016
Asia-Pacific
Several legislative changes affecting data exclusivity of biologic drugs in Vietnam are poised to come into effect, and companies operating in this sector should take note now, as Hien Thi Thu Vu and Huong Lan Nguyen of Tilleke & Gibbins explain. 14 July 2016
Americas
A US court has sided with Forest Laboratories in a dispute with Mylan Pharmaceuticals centring on the Savella drug. 13 July 2016
Americas
AstraZeneca announced today that it has entered into an agreement with Sandoz to resolve patent litigation between the two companies. 13 July 2016
Americas
Nichi-Iko Pharmaceutical, a Tokyo-based drugs company, will acquire Illinois-based Sagent Pharmaceuticals for $736 million in cash. 13 July 2016
Americas
An en banc US Court of Appeals for the Federal Circuit said yesterday that two patents owned by The Medicines Company are valid in a case setting the rules for ‘on-sale’ product-by process patents. 12 July 2016
Americas
Merck Sharp & Dohme has filed a lawsuit against Genentech asking the US District Court for the Central District of California to re-evaluate a patent belonging to Genentech. 11 July 2016
Americas
The US Food and Drug Administration has said that an Amgen biosimilar is indeed “highly similar” to AbbVie’s drug Humira in a document released for the advisory committee panel meeting due to be held tomorrow. 11 July 2016
Asia
Healthcare provider Zydus Cadila has signed a sub-licensing agreement with the Medicines Patent Pool (MPP) centring on the generic production of Daklinza (daclatasvir). 8 July 2016
Big Pharma
The Court of Justice of the European Union has said the beneficiary of a patent licence must pay the agreed royalty rate even if it does not infringe the patented technology. 7 July 2016